The Microbiome and Acne: Perspectives for Treatment

Clio Dessinioti,Andreas Katsambas

DOI: https://doi.org/10.1007/s13555-023-01079-8

2024-01-07

Dermatology and Therapy

Abstract:The skin microbiome consists of the microorganisms populating the human skin. Cutibacterium acnes ( C. acnes , formerly named Propionibacterium acnes ) is recognized as a key factor in acne development, regulating inflammatory and immune pathways. Dysbiosis has been described as the imbalance in skin microbiome homeostasis and may play a role in acne pathogenesis. Microbial interference has been shown to be a contributor to healthy skin homeostasis and staphylococcal strains may exclude acne-associated C. acnes phylotypes. In this review we present an update on the skin microbiome in acne and discuss how current acne treatments such as benzoyl peroxide, orally administered isotretinoin, and antibiotics may affect the skin microbiome homeostasis. We highlight the collateral damage of acne antibiotics on the skin microbiome, including the risk of antimicrobial resistance and the dysregulation of the microbiome equilibrium that may occur even with short-term antibiotic courses. Consequently, the interest is shifting towards new non-antibiotic pharmacological acne treatments. Orally administered spironolactone is an emerging off-label treatment for adult female patients and topical peroxisome proliferator-activated receptor gamma (PPARγ) modulation is being studied for patients with acne. The potential application of topical or oral probiotics, bacteriotherapy, and phage therapy for acne are further promising areas of future research.

dermatology

What problem does this paper attempt to address?

The paper attempts to address the issue of the impact of the skin microbiome on acne treatment and its potential new non-antibiotic therapies. Specifically:

1. **The relationship between the skin microbiome and acne**: The paper explores the role of the skin microbiome (particularly *Cutibacterium acnes*) in the pathogenesis of acne and discusses how dysbiosis of the skin microbiome can influence the occurrence and development of acne.

2. **The impact of existing acne treatments on the microbiome**: The paper analyzes the effects of currently approved acne treatments (such as benzoyl peroxide, oral isotretinoin, and antibiotics) on the skin microbiome, especially the issues of microbiome imbalance and antibiotic resistance that these treatments may cause.

3. **New non-antibiotic therapies**: In light of the risks associated with antibiotic use, the paper also explores some emerging non-antibiotic therapies, including spironolactone, PPARγ modulators, probiotic therapy, and phage therapy. These methods may help maintain the balance of the skin microbiome and reduce dependence on antibiotics.

Through these studies, the paper aims to promote improvements in acne treatment strategies, particularly in finding effective alternatives while reducing the use of antibiotics.